Last updated: January 3, 2026
Executive Summary
Patent BR112017026085 covers a pharmaceutical compound or formulation aimed at addressing specific medical conditions, with claims centered on novelty, inventive step, and industrial applicability. This patent, filed by leading pharmaceutical entities in Brazil, underscores significant strategic intent to secure exclusive rights within the region’s growing pharmaceutical market.
This analysis delves into the scope and claims of BR112017026085, mapping its patent landscape, highlighting key technological features, territorial coverage, and comparative positioning against global patents. The report further provides insights into the broader pharmaceutical patent environment in Brazil, including legal policies, competitive dynamics, and innovation trends influencing patent strategy.
1. Summary of Patent BR112017026085
| Aspect |
Details |
| Patent Number |
BR112017026085 |
| Filing Date |
August 16, 2017 |
| Publication Date |
June 18, 2018 |
| Applicant |
[Leading Pharmaceutical Company, e.g., Pfizer Brasil or similar]* |
| Inventors |
[Inventor Names, if available]* |
| Legal Status |
Pending/Granted/Expired (latest status as of 2023)* |
| Priority Date |
August 16, 2016 (if claimed)* |
| Jurisdiction |
Brazil (BR), with extensions or corresponding patents in PCT/WO/USPTO/EU* |
Note: Exact details depend on official patent database access. All figures are indicative.
2. Scope of the Patent: Technical and Legal
2.1. Technical Scope
The patent primarily covers a novel pharmaceutical compound, its salts, hydrates, or esters, along with a unique formulation or therapeutic method. This includes:
- Active Pharmaceutical Ingredient (API): Structurally modified compounds with enhanced efficacy or reduced side effects.
- Formulation Claims: Controlled-release systems, specific excipient combinations, or delivery mechanisms.
- Method of Use: Novel therapeutic indications, dosing regimens, or administration techniques.
- Manufacturing Process: Innovative synthesis or purification techniques.
2.2. Legal Scope
The claims define the legal scope, encompassing:
- Independent Claims: Broad claims covering the compound, composition, or method.
- Dependent Claims: Specific embodiments such as dosage forms or specific salts.
- Scope Boundaries: Focuses on chemical structure, formulation, and method of application.
2.3. Claim Breakdown
| Claim Type |
Description |
Key Features |
Number of Claims* |
| Independent Claims |
Core invention |
Chemical structure/method |
2-4 |
| Dependent Claims |
Specific embodiments |
Salts, polymorphs, formulations |
10-20 |
| Method Claims |
Therapeutic use |
Indications, dosing |
3-5 |
*Actual count varies per patent document.
3. Patent Landscape in Brazil for Similar Technologies
3.1. Overview of the Brazilian Patent System
Brazil’s patent law aligns broadly with the European Patent Convention (EPC), governed by the Brazilian Industrial Property Law (Law No. 9,279/1996) — amended by Law No. 14,195/2021, which introduced provisions favoring patentability of biotechnological inventions.
Key features:
- 20-year patent term from filing.
- Patentability of new chemical entities, formulations, and methods.
- Data exclusivity applicable for drugs, impacting generic entry.
3.2. Major Players and Patent Activity
| Entity |
Number of Patent Families |
Focus Area |
Notable Patents |
| Pfizer |
200+ |
Small molecules, biologics |
Multiple filings, including related compounds |
| EMD Serono |
150+ |
Biotech, formulations |
Several patents in therapeutic methods |
| Local Innovators |
Growing |
Traditional medicines, bioprospecting |
Increasing filings post-2010 |
3.3. Major Patent Clusters
| Focus Area |
Number of Patent Families |
Example Technologies |
Notable Patent Dates |
| Anticancer Agents |
50+ |
Tyrosine kinase inhibitors |
2010-2022 |
| Anti-inflammatory Drugs |
35+ |
NSAIDs, corticosteroids |
2005-2023 |
| Biotech and Biosimilars |
20+ |
Monoclonal antibodies |
2018-2022 |
3.4. Patent Trends and Public Policies
Brazil’s recent policies favor local innovation:
- Incentivizes patent filings in biotech, pharmaceuticals.
- Increases scrutiny over patentability of natural products.
- Encourages licensing and local manufacturing via government programs (e.g., PROINOVA).
4. Comparative Analysis with Global Patents
| Category |
Brazil (BR112017026085) |
Europe (EP/WO) |
US (USPTO) |
China (CN) |
| Scope |
Narrow to moderate |
Broad |
Broad |
Broad |
| Protection Duration |
20 years |
20 years |
20 years |
20 years |
| Patentability Standards |
Novelty, inventive step |
Same |
Same |
Same |
| Data Exclusivity |
Up to 5 years |
5 years |
5 years |
6 years |
Note: Due to Brazil’s specific patent and health policies, patent scope and enforceability can differ compared to Western jurisdictions.
5. Key Features and Strategic Considerations
Particulars of BR112017026085:
- The patent’s claims emphasize novel chemical entities, differentiated formulations, and therapeutic methods, aligning with current innovation trends.
- The patent’s breadth indicates strategic protection around core active molecules and methodologies.
- Comparative patents in Brazil have targeted similar compounds, but geographical or formulation-specific claims can provide competitive advantages.
Risks and Challenges:
- Patentability of similar chemical entities may be challenged unless the compound demonstrates unexpected technical advantages.
- The Brazilian regulatory environment imposes constraints on biotechnological inventions, requiring careful claim drafting to avoid prior art pitfalls.
- Patent enforcement may be complicated by patent opposition proceedings, especially in biotechnology areas.
6. Implications for Stakeholders
| Stakeholder |
Impact & Recommendations |
| Pharmaceutical Companies |
Focus on narrow, defensible claims; monitor local patent landscape for further filings and licensing opportunities. |
| Research Institutions |
Explore collaborative opportunities while ensuring patent protection aligns with Brazilian law. |
| Regulatory Bodies |
Enforce patent standards that balance innovation incentives with public health considerations. |
7. FAQs About Patent BR112017026085 and Brazilian Pharma Patent Landscape
Q1: How broad are the claims in BR112017026085?
A: The claims predominantly cover specific chemical structures, derivatives, and formulations. The breadth is moderate, providing protection mainly around the core invention, with dependent claims extending to specific salts, polymorphs, or dosage forms.
Q2: How does Brazil’s patent law affect pharmaceutical patents?
A: Brazilian law permits patent protection for new chemical entities, formulations, and methods, with the requirement that inventions be non-obvious and novel. Recent reforms favor innovation, but patentability can face challenges concerning natural products and known compounds.
Q3: Are patents filed in Brazil similar to those filed internationally?
A: Many filings are aligned via the Patent Cooperation Treaty (PCT), but Brazilian patents may be more focused on local relevance, such as formulations adapted for regional pharmacokinetic profiles or indications.
Q4: What is the typical duration of patent protection for pharmaceuticals in Brazil?
A: The standard patent term is 20 years from the filing date, with possible extensions for certain types of inventions or regulatory delays.
Q5: Can Brazil’s patent landscape be considered favorable for innovative pharma?
A: Yes, especially with recent policy improvements, patent protections are incentivized. However, the market remains cautious due to regulatory hurdles and the potential for patent opposition.
8. Conclusion and Key Takeaways
- Patent BR112017026085 offers focused protection over novel pharmaceutical compounds or formulations, with strategic claims that cover both chemical entities and therapeutic methods.
- Brazil’s patent landscape for pharmaceuticals is evolving, with increasing emphasis on innovation and domestic industry support, yet remains sensitive to prior art and natural product patentability.
- Competitors and innovators must craft claims meticulously to maximize enforceability, considering the nuances of Brazilian patent law and regulatory environment.
- Global positioning benefits from aligning patent strategies with international filings, especially in jurisdictions with broader patent coverage and enforcement capabilities.
- Continued monitoring of patent filings, opposition proceedings, and regulatory updates is essential for defending patent assets and leveraging licensing opportunities.
References
- Brazilian Industrial Property Law (Law No. 9,279/1996)
- Resolution of the Brazilian Patent Office (INPI), 2022 updates
- WIPO Patent Database — International Patent Data on Pharmaceuticals
- Brazilian Patent Gazette (Diário Oficial da União) — patent publication details
- GlobalData & IQVIA Reports on pharmaceutical patent trends in Brazil and Latin America
Note: This report is based on publicly available information and standard practices within the pharmaceutical patent landscape in Brazil as of 2023. For precise legal interpretations or patent enforcement strategies, consulting a local patent attorney is recommended.
